{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:09:01Z","timestamp":1763507341240,"version":"3.45.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11968-2","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:29:18Z","timestamp":1763461758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and risk factors associated with 28-day mortality among maintenance hemodialysis patients infected with Omicron variant of SARS-CoV-2"],"prefix":"10.1186","volume":"25","author":[{"given":"Yin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"2","key":"11968_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1681\/ASN.2020060875","volume":"32","author":"J De Meester","year":"2021","unstructured":"De Meester J, De Bacquer D, Naesens M, et al. Incidence, Characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: A regionwide registry study. J Am Soc Nephrol. 2021;32(2):385\u201396.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"11968_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.kint.2020.07.042","volume":"98","author":"C Couchoud","year":"2020","unstructured":"Couchoud C, Bayer F, Ayav C, et al. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French National cohort of Dialysis patients. Kidney Int. 2020;98(6):1519\u201329.","journal-title":"Kidney Int"},{"issue":"6","key":"11968_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.kint.2020.07.030","volume":"98","author":"JH Ng","year":"2020","unstructured":"Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6):1530\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"11968_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.kint.2020.04.030","volume":"98","author":"F Alberici","year":"2020","unstructured":"Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia renal COVID task force on the clinical characteristics and short-term outcome of Hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020;98(1):20\u20136.","journal-title":"Kidney Int"},{"issue":"11","key":"11968_CR5","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/ndt\/gfaa261","volume":"35","author":"LB Hilbrands","year":"2020","unstructured":"Hilbrands LB, Duivenvoorden R, Vart P, et al. COVID-19-related mortality in kidney transplant and Dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplantation. 2020;35(11):1973\u201383.","journal-title":"Nephrol Dial Transplantation"},{"issue":"5","key":"11968_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.kint.2022.01.022","volume":"101","author":"K El Karoui","year":"2022","unstructured":"El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. Kidney Int. 2022;101(5):883\u201394.","journal-title":"Kidney Int"},{"issue":"1","key":"11968_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/22221751.2022.2060137","volume":"11","author":"P-HH Cheung","year":"2022","unstructured":"Cheung P-HH, Chan C-P, Jin D-Y. Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect. 2022;11(1):1072\u20138.","journal-title":"Emerg Microbes Infect"},{"issue":"7821","key":"11968_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using opensafely. Nature. 2020;584(7821):430\u20136.","journal-title":"Nature"},{"key":"11968_CR9","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.lanepe.2021.100158","volume":"8","author":"L Semenzato","year":"2021","unstructured":"Semenzato L, Botton J, Drouin J, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in france: a cohort study of 66 million people. Lancet Reg Health Eur. 2021;8:100158.","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"11968_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","volume":"26","author":"M Syed-Ahmed","year":"2019","unstructured":"Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):8\u201315.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"7","key":"11968_CR11","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1681\/ASN.2020030354","volume":"31","author":"F Xiong","year":"2020","unstructured":"Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in Hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020;31(7):1387\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"11968_CR12","doi-asserted-by":"crossref","unstructured":"Turgutalp K, Ozturk S, Arici M, et al. Determinants of mortality in a large group of Hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021(1);29.","DOI":"10.1186\/s12882-021-02233-0"},{"issue":"1","key":"11968_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12879-023-08620-2","volume":"23","author":"Y Guo","year":"2023","unstructured":"Guo Y, Guo Y, Ying H, et al. In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the Omicron variant of SARS-CoV-2: a single-center retrospective study. BMC Infect Dis. 2023;23(1):698.","journal-title":"BMC Infect Dis"},{"key":"11968_CR14","unstructured":"Agarwal A, Hunt B, Stegemann M, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020 (370):m3379."},{"key":"11968_CR15","first-page":"o1045","volume":"377","author":"A living WHO guideline on drugs for covid-19","year":"2022","unstructured":"A living WHO guideline on drugs for covid-19. BMJ. 2022;377:o1045.","journal-title":"BMJ"},{"issue":"11","key":"11968_CR16","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.34067\/KID.0004502020","volume":"1","author":"D Kular","year":"2020","unstructured":"Kular D, Chis Ster I, Sarnowski A, et al. The Characteristics, Dynamics, and the risk of death in COVID-19 positive Dialysis patients in London. UK Kidney360. 2020;1(11):1226\u201343.","journal-title":"UK Kidney360"},{"issue":"8","key":"11968_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.34067\/KID.0003672020","volume":"1","author":"M Fisher","year":"2020","unstructured":"Fisher M, Yunes M, Mokrzycki MH, et al. Chronic Hemodialysis patients hospitalized with COVID-19: Short-term outcomes in the Bronx. New York Kidney360. 2020;1(8):755\u201362.","journal-title":"New York Kidney360"},{"issue":"1","key":"11968_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.kint.2020.04.031","volume":"98","author":"M Goicoechea","year":"2020","unstructured":"Goicoechea M, Camara LAS, Mac\u0131as N, et al. COVID-19: clinical course and outcomes of 36 Hemodialysis patients in Spain. Kidney Int. 2020;98(1):27\u201334.","journal-title":"Kidney Int"},{"key":"11968_CR19","doi-asserted-by":"crossref","unstructured":"Bao WJ, Fu SK, Zhang H, et al. Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-CoV-2 omicron BA.2.2.1 variant in Shanghai, China. New Microbes New Infect. 2022;49: 101058.","DOI":"10.1016\/j.nmni.2022.101058"},{"issue":"7","key":"11968_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2023","unstructured":"Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA-Cardiol. 2023;5(7):811\u20138.","journal-title":"JAMA-Cardiol"},{"issue":"7","key":"11968_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"S Shi","year":"2020","unstructured":"Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA-Cardiol. 2020;5(7):802\u201310.","journal-title":"JAMA-Cardiol"},{"issue":"2","key":"11968_CR22","first-page":"91","volume":"7","author":"S Aggarwal","year":"2020","unstructured":"Aggarwal S, Garcia-Telles N, Aggarwal G, et al. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the united States. Dignosis. 2020;7(2):91\u20136.","journal-title":"Dignosis"},{"issue":"4","key":"11968_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.medcli.2021.09.014","volume":"159","author":"ZQ Zhang","year":"2022","unstructured":"Zhang ZQ, Wan JQ, Zhu SK, et al. Analysis of cardiovascular disease factors on SARS-CoV-2 infection severity. Med Clin. 2022;159(4):171\u20136.","journal-title":"Med Clin"},{"issue":"10","key":"11968_CR24","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666\u201387.","journal-title":"Cardiovasc Res"},{"key":"11968_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fmed.2020.00532","volume":"7","author":"L Zou","year":"2020","unstructured":"Zou L, Dai L, Zhang Y, et al. Clinical characteristics and risk factors for disease severity and death in patients with coronavirus disease 2019 in Wuhan, China. Front Med. 2020;7:532.","journal-title":"Front Med"},{"issue":"1","key":"11968_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12967-020-02571-x","volume":"18","author":"J Zhang","year":"2020","unstructured":"Zhang J, Hao Y, Ou W, et al. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J Transl Med. 2020;18(1):406.","journal-title":"J Transl Med"},{"issue":"6","key":"11968_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","volume":"326","author":"WHO Rapic Evidence Appraisal for COVID-19 Therapies (REACT) Working Group","year":"2021","unstructured":"WHO Rapic Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: A Meta-analysis. JAMA-J Am Med Assoc. 2021;326(6):499\u2013518.","journal-title":"JAMA-J Am Med Assoc"},{"issue":"1","key":"11968_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmi.2022.07.008","volume":"29","author":"AM Albuquerque","year":"2023","unstructured":"Albuquerque AM, Eckert I, Tramujas L, et al. Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(1):13\u201321.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"11968_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40620-020-00960-5","volume":"34","author":"H Hendra","year":"2021","unstructured":"Hendra H, Vajgel G, Antonelou M, et al. Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty. J Nephrol. 2021;34(2):315\u201323.","journal-title":"J Nephrol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11968-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:05:35Z","timestamp":1763507135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11968-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11968"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11968-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Helsinki Declaration. The study protocol was approved by the Human Research and Ethics Committee of Huashan Hospital Affiliated to Fudan University (KY2022-582). Informed consent was obtained from all participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1608"}}